Drug intelligence / Profile preview

ethylestrenol

Development stage
Discontinued
Lead developer
Organon
Modality
Small Molecules
Administration
Oral
01

Overview

Ethylestrenol is a synthetic androgen and anabolic steroid (AAS) that was formerly used in humans to promote weight gain and treat conditions such as anemia and osteoporosis, but has since been discontinued for human use. It remains available for veterinary purposes in some countries. The drug acts primarily as an agonist of the androgen receptor, exhibiting strong anabolic effects relative to its weak androgenic activity, and also possesses significant progestogenic properties. Ethylestrenol is a 17α‐ethylated derivative of nandrolone and functions as a prodrug of norethandrolone. Its mechanism involves binding to the androgen receptor, modulating gene expression related to cellular proliferation and differentiation. Side effects include masculinization symptoms and risk of liver toxicity due to its 17α‐alkylation[3][5][6].

Brand names
MaxibolinOrabolin
Other names
ethyloestrenolethylnandrol17beta-Hydroxy-17alpha-ethyl-19-nor-androsteneEthylnandrol (JAN)ETHYLNANDROL [JAN]Etilestrenol (INN-Spanish)Ethylestrenolum (INN-Latin)
02

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on ethylestrenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethylestrenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call